Hoosiers are catching on: Indiana is becoming a hotbed of health science innovations. A big reason is the Indiana Clinical and Translational Sciences Institute, or Indiana CTSI. This bench-to-bedside research group includes scientists from IU, Notre Dame, and Purdue as well as from companies such as the Cook Group and Eli Lilly. The CTSI provides funding for researchers tackling multiple sclerosis, bone regeneration, breast cancer, and Parkinson’s disease.

But equally importantly, the Indiana CTSI provides a forum for involving regular citizens, non-scientists, in research. When people in Indiana realize that they can actually aid scientific discovery by testing a new medication or donating healthy tissue to a biobank, they get a concrete understanding of how their state, Indiana, is on the forefront of the life sciences – and commercial developments in medicine.

See the Indiana CTSI website.